share_log

基蛋生物(603387.SH):此次安徽发光集采项目占公司目前发光试剂项目收入的比例较小

BaseEgg Biology (603387.SH): The current luminescence collection project in Anhui accounts for a small proportion of the company's current luminescence reagent project revenue

Gelonghui Finance ·  Nov 8, 2023 03:21

Gelonghui November 8th 丨Kiegobio (603387.SH) is inAt the online performance briefing, it was stated thatJudging from the company's chemiluminescence reagent revenue structure, the myocardial category accounts for 85%, and inflammation and tumors account for about 10% in total. At this stage, chemiluminescence mainly focuses on myocardial and inflammation tests. In the future, with the gradual coverage of small assembly lines, it will drive an increase in testing programs for infectious diseases, diathesis, and tumors. This time, the Anhui luminescence collection project accounts for a small proportion of the company's current luminescence reagent project revenue, and has little impact on the company's chemiluminescence business.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment